Refine by
Opko Medical Equipment & Supplies In In Grenada
9 equipment items found
Manufactured by:OPKO Health, Inc. based inMiami, FLORIDA (USA)
Selective Androgen Receptor Modulators (SARMs) have recently garnered attention as possible therapeutic agents due to their increased specificity for anabolic androgen receptors, and yet potentially serving as an antagonist to androgen receptors in the prostate. OPK88004 is being assessed as a treatment for muscle wasting, decreased physical strength and function, sarcopenia, and frailty in end ...
Manufactured by:OPKO Health, Inc. based inMiami, FLORIDA (USA)
Our reversible PEGylation technology is a novel technique for creating extended release therapeutics. In reversible PEGylation, a conjugate is formed through a proprietary bi-functional hydrolyzable linker, between a drug that contains a primary peptide and a polyethylene glycol (PEG) chain. Once the conjugate enters the bloodstream the linker hydrolyzes at physiological pH and body temperature, ...
Manufactured by:OPKO Health, Inc. based inMiami, FLORIDA (USA)
Somatrogon, a long-acting human growth hormone (hGH) molecule, is a once-weekly injectable, created using recombinant technology, for the treatment of pediatric and adult growth hormone deficiency (GHD). The molecule consists of the natural peptide sequence of native growth hormone and the 28 amino acids of the C-Terminus Peptide (CTP) of the human chorionic gonadotropin hormone. This molecule, ...
Manufactured by:OPKO Health, Inc. based inMiami, FLORIDA (USA)
Rayaldee® (calcifediol) is an extended-release prohormone of the active form of vitamin D3 that both raises 25-hydroxyvitamin D and lowers intact parathyroid hormone (iPTH) levels in patients with stage 3 or 4 CKD. Rayaldee® is under development for adult patients with stage 5 chronic kidney disease (CKD) with SHPT and vitamin D insufficiency who require regular ...
Manufactured by:OPKO Health, Inc. based inMiami, FLORIDA (USA)
In our Natural Antisense Transcripts Antagonist (AntagoNAT) technology, an oligonucleotide molecule is designed to interfere with regulatory gene expression in order to enhance production of endogenous functional proteins. This strategy is unique and contrasts with established approaches which down-regulate protein production. This platform can lead to the discovery of new drugs to target ...
Manufactured by:OPKO Health, Inc. based inMiami, FLORIDA (USA)
The 4Kscore® Test is used by health care professionals to improve the accuracy of prostate cancer diagnosis after an abnormal prostate-specific antigen (PSA) test result, or digital rectal exam, before the decision is made to biopsy. The 4Kscore® Test provides a risk score (4KScore) for finding aggressive prostate cancer based on combined serum concentrations of four prostate specific ...
Manufactured by:OPKO Health, Inc. based inMiami, FLORIDA (USA)
Our Carboxyl Terminal Peptide (CTP) technology is used to extend the half-lives of pharmacologically active proteins. CTP uses recombinant technology to fuse a short, naturally occurring 28 amino acid sequence (a CTP) to a pharmacologically active protein which results in slower excretion of the therapeutic protein, thus, extending the protein's half-life. At OPKO, we are currently use CTP ...
Manufactured by:OPKO Health, Inc. based inMiami, FLORIDA (USA)
The Claros 1 device is a point-of-care, bench top diagnostic instrument system designed to provide rapid, quantitative blood test results in 15 minutes, right in the physician's office, using a fingerstick of whole blood. The Sangia Total PSA Claros 1 test, which provides measurements comparable to large instruments used in central reference laboratories, received FDA approval in January 2019. ...
Manufactured by:OPKO Health, Inc. based inMiami, FLORIDA (USA)
Oxyntomodulin is a naturally occurring hormone produced in the colon, shown to bind both the GLP-1 and glucagon receptor, regulating both blood glucose appetite and lipid metabolism. OPKO Health is developing OPK88003, a long-acting, once weekly oxyntomodulin analog for the treatment of type 2 diabetes and ...